CClinicalTrials.gg
CompletedNCT00349323Updated May 8, 2008

Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in Zambia

An observational study in Soil-Transmitted Helminth Infection and Growth, sponsored by DBL -Institute for Health Research and Development. Completed at 1 site in Zambia. Open to participants aged 12 Months to 59 Months. Per ClinicalTrials.gov, last updated 2008-05-08.

Sponsored by DBL -Institute for Health Research and Development · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
100
Ages
12 Months to 59 Months
Sex
All
01

Study summary

The WHO Special Programme for Research and Training in Tropical Diseases (TDR) developed a Community-Directed Treatment (COMDT) approach, which has been adopted in the control of onchocerciasis and lymphatic filariasis. WHO has recommended the use of COMDT approach in the control of schistosomiasis and STH infections. The COMDT approach has been compared with the school based programmes in certain African countries,but not with the health-facility based approach.

The project will be implemented in Mazabuka district of Zambia where COMDT approach will be implemented in the catchment area of Rural Health Centres (RHC) as a supplement to the health-facility-based approach. After each round of treatmenttreatment coverage and factors responsible for the treatment coverage will be measured in both areas. The health impact of the health facility based approach with and without the COMDT approach will be compared. The effect of the COMDT as a control approach of STH infections will be monitored on infections in the community of children aged 12 to 59 months.

Read the detailed description

Soil-transmitted helminth (STH) infections are of public health importance and widespread in large part of the world, particularly in the poorest sections of the populations residing in the least developed countries. The infections can be controlled by several measures, but currently delivering anthelminthic drugs through schools and health centres is believed to be the most effective as it takes advantage of existing infrastructure. In Zambia, anthelminthic drugs are delivered to children aged 12 to 59 months twice a year through health facilities during the child health promotion week. However, it has been observed that treatment coverage is low in certain areas. Therefore, there is a need to identify the factors associated with the treatment coverage patterns, and to provide evidence of an effective intervention approach that could increase the proportion of children receiving treatment.

The WHO Special Programme for Research and Training in Tropical Diseases (TDR) developed a Community-Directed Treatment (COMDT) approach, which has been adopted in the control of onchocerciasis and lymphatic filariasis. WHO has recommended the use of COMDT approach in the control of schistosomiasis and STH infections. The COMDT approach has been compared with the school based programmes in certain African countries, but has never been used in Zambia and never been compared with the health-facility based approach in the control of these infections in children below school age. It is against this background that this project is being proposed.

The project will be implemented in Mazabuka district of Zambia. Two Rural Health Centres (RHCs) will be selected in the district and mapped for treatment coverage of the health-facility based approach. Focus group discussions (FGDs) and in-depth interviews will be conducted with community members to explore the reasons for existing treatment coverage of the health facility approach. The COMDT approach will then be implemented in the catchment area of one of the RHCs as a supplement to the health-facility-based approach. After each round of treatment, coverage and factors influencing coverage will be measured in both areas. The health impact of the health facility based approach with and without the COMDT approach will be compared. Parameters for health impact will be child growth, prevalence and intensity of STH infections and number of illness episodes requiring treatment. The effect of the COMDT as a control approach of STH infections will be monitored on infections in the community of children aged 12 to 59 months, and the appropriateness of the approach will be evaluated using the African Programme for Onchocerciasis Control grading system. The whole project is expected to take 3 years.

02

Conditions studied

  • Soil-Transmitted Helminth Infection
  • Growth

Browse trials for

Keywords

  • Community directed treatment,
  • soil-transmitted helminth infections,
  • treatment coverage,
  • Zambia
03

In context

Helminthiasis

64 studies on the registry are indexed under Helminthiasis; 4 are open to participants now.

This study's planned enrollment of 100 is below the median of 312 across 22 observational studies indexed under Helminthiasis.

Browse Helminthiasis studies →

Lead sponsor

DBL -Institute for Health Research and Development is the lead sponsor of 20 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 59 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 12-59 months

Exclusion criteria

Exclusion Criteria:

  • Severely ill children
05

Study design

Time perspective
Prospective
Enrollment
100 participants (estimated)

Interventions

  • BehavioralCommunity directed treatment
06

Study locations

1 site
  • Mazabuka District
    Mazabuka, Zambia
07

References and documents

Publications

  • Halwindi H, Magnussen P, Meyrowitsch D, Handema R, Siziya S, Olsen A. Effect on treatment coverage of adding community-directed treatment to the health facility-based approach of delivering anthelminthic drugs to under-five children during child health week in Mazabuka District, Zambia. Int Health. 2010 Dec;2(4):253-61. doi: 10.1016/j.inhe.2010.09.003. PubMed 24037866 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00349323
Lead sponsor
DBL -Institute for Health Research and Development
Collaborators
Department of Community Medicine & Department of Biological Sciences, University of Zambia
First posted
Jul 7, 2006
Start date
Aug 2006
Primary completion
Aug 2007
Completion
Sep 2007
Last update
May 8, 2008

Study contacts

Hikabasa Halwindi, M.phil
principal investigator · Department of Community Medicine, University of Zambia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion